Use of to Unravel the Tripartite Interaction of Kynurenine Pathway, UPR and Microbiome in Parkinson's Disease

Overview

Journal Biomolecules

Publisher MDPI

Specialties Biochemistry
Molecular Biology

Date 2024 Nov 27

PMID 39595547

Authors

Charles Viau

Alyssa Nouar

Jianguo Xia

Affiliations

Soon will be listed here.

Abstract

The model organism and its relationship with the gut microbiome are gaining traction, especially for the study of neurodegenerative diseases such as Parkinson's Disease (PD). Gut microbes are known to be able to alter kynurenine metabolites in the host, directly influencing innate immunity in . While the mitochondrial unfolded protein response (UPR) was first characterized in in 2007, its relevance in host-microbiome interactions has only become apparent in recent years. In this review, we provide novel insights into the current understanding of the microbiome-gut-brain axis with a focus on tripartite interactions between the UPR, kynurenine pathway, and microbiome in , and explore their relationships for PD remediations.

References

Yang J, Wu X, Song Y . Recent advances in novel mutation genes of Parkinson's disease. J Neurol. 2023; 270(8):3723-3732. DOI: 10.1007/s00415-023-11781-4. View

Arsenijevic D, Onuma H, Pecqueur C, Raimbault S, Manning B, Miroux B . Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production. Nat Genet. 2000; 26(4):435-9. DOI: 10.1038/82565. View

Romano S, Savva G, Bedarf J, Charles I, Hildebrand F, Narbad A . Meta-analysis of the Parkinson's disease gut microbiome suggests alterations linked to intestinal inflammation. NPJ Parkinsons Dis. 2021; 7(1):27. PMC: 7946946. DOI: 10.1038/s41531-021-00156-z. View

Pujol N, Link E, Liu L, Kurz C, Alloing G, Tan M . A reverse genetic analysis of components of the Toll signaling pathway in Caenorhabditis elegans. Curr Biol. 2001; 11(11):809-21. DOI: 10.1016/s0960-9822(01)00241-x. View

Govindan J, Jayamani E, Zhang X, Mylonakis E, Ruvkun G . Dialogue between E. coli free radical pathways and the mitochondria of C. elegans. Proc Natl Acad Sci U S A. 2015; 112(40):12456-61. PMC: 4603447. DOI: 10.1073/pnas.1517448112. View

Martinez B, Petersen D, Gaeta A, Stanley S, Caldwell G, Caldwell K . Dysregulation of the Mitochondrial Unfolded Protein Response Induces Non-Apoptotic Dopaminergic Neurodegeneration in Models of Parkinson's Disease. J Neurosci. 2017; 37(46):11085-11100. PMC: 5688521. DOI: 10.1523/JNEUROSCI.1294-17.2017. View

Salat-Foix D, Tran K, Ranawaya R, Meddings J, Suchowersky O . Increased intestinal permeability and Parkinson disease patients: chicken or egg?. Can J Neurol Sci. 2012; 39(2):185-8. DOI: 10.1017/s0317167100013202. View

Berg M, Zhou X, Shapira M . Host-Specific Functional Significance of Gut Commensals. Front Microbiol. 2016; 7:1622. PMC: 5066524. DOI: 10.3389/fmicb.2016.01622. View

Zhang J, Liu Y, Zhi X, Xu L, Tao J, Cui D . Tryptophan catabolism via the kynurenine pathway regulates infection and inflammation: from mechanisms to biomarkers and therapies. Inflamm Res. 2024; 73(6):979-996. DOI: 10.1007/s00011-024-01878-5. View

10.

Jaronen M, Quintana F . Immunological Relevance of the Coevolution of IDO1 and AHR. Front Immunol. 2014; 5:521. PMC: 4202789. DOI: 10.3389/fimmu.2014.00521. View

11.

Pohl C, Dikic I . Cellular quality control by the ubiquitin-proteasome system and autophagy. Science. 2019; 366(6467):818-822. DOI: 10.1126/science.aax3769. View

12.

Agus A, Planchais J, Sokol H . Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease. Cell Host Microbe. 2018; 23(6):716-724. DOI: 10.1016/j.chom.2018.05.003. View

13.

Shiri T, Viau C, Gu X, Xu L, Lu Y, Xia J . The Native Microbiome Member sp. CHNTR56 MYb120 Induces Trehalose Production via a Shift in Central Carbon Metabolism during Early Life in . Metabolites. 2023; 13(8). PMC: 10456584. DOI: 10.3390/metabo13080953. View

14.

Lu Y, Li X, Liu S, Zhang Y, Zhang D . Toll-like Receptors and Inflammatory Bowel Disease. Front Immunol. 2018; 9:72. PMC: 5797585. DOI: 10.3389/fimmu.2018.00072. View

15.

Anwardeen N, Diboun I, Mokrab Y, Althani A, Elrayess M . Statistical methods and resources for biomarker discovery using metabolomics. BMC Bioinformatics. 2023; 24(1):250. PMC: 10266963. DOI: 10.1186/s12859-023-05383-0. View

16.

Mor D, Sohrabi S, Kaletsky R, Keyes W, Tartici A, Kalia V . Metformin rescues Parkinson's disease phenotypes caused by hyperactive mitochondria. Proc Natl Acad Sci U S A. 2020; 117(42):26438-26447. PMC: 7585014. DOI: 10.1073/pnas.2009838117. View

17.

Calabresi P, Mechelli A, Natale G, Volpicelli-Daley L, Di Lazzaro G, Ghiglieri V . Alpha-synuclein in Parkinson's disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction. Cell Death Dis. 2023; 14(3):176. PMC: 9977911. DOI: 10.1038/s41419-023-05672-9. View

18.

Ortiz de Ora L, Bess E . Emergence of Caenorhabditis elegans as a Model Organism for Dissecting the Gut-Brain Axis. mSystems. 2021; 6(4):e0075521. PMC: 8407351. DOI: 10.1128/mSystems.00755-21. View

19.

Tian D, Han M . Bacterial peptidoglycan muropeptides benefit mitochondrial homeostasis and animal physiology by acting as ATP synthase agonists. Dev Cell. 2022; 57(3):361-372.e5. PMC: 8825754. DOI: 10.1016/j.devcel.2021.12.016. View

20.

Maroteaux L, Scheller R . The rat brain synucleins; family of proteins transiently associated with neuronal membrane. Brain Res Mol Brain Res. 1991; 11(3-4):335-43. DOI: 10.1016/0169-328x(91)90043-w. View